RecruitingPhase 3NCT06378021

Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG

Post Operative Atrial Fibrillation: Alleviation by Calcium Chloride Injection Into Cardiac Ganglionic Plexus During Coronary Artery Bypass Grafting.


Sponsor

Helwan University

Enrollment

100 participants

Start Date

Mar 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study hypothesize that injecting calcium chloride (CaCl2) into the major atrial ganglionated plexus (GPs) during on pump Coronary artery bypass graft (CABG) can reduce the incidence of Post operative Atrial fibrillation in the first 7 days after surgery.The study is designed to be prospective interventional study two armed RCT for on pump CABG patient. The intervention arm will be injected with Calcium chloride in the four major atrial ganglionic plexus The control arm will be injected with sodium chloride to determine the effect of Calcium chloride on Post CABG Atrial fibrillation


Eligibility

Min Age: 18 YearsMax Age: 74 Years

Inclusion Criteria1

  • \) Patients more than 18 years old 2 ) patients undergoing On pump CABG

Exclusion Criteria4

  • patients \>75 years of age
  • Patients with Pre operative Atrial fibrillation
  • Patients with Significant valvular disease
  • \. Ejection fraction \<30% 6. Combined surgery of any kind 7. Congenital heart disease 8. Abnormal severe liver or kidney dysfunction. 9. Patients undergoing Off-pump CABG 10. Poorly controlled hyperthyroidism 11. Refusal to enrollment.

Interventions

DRUGCalcium Chloride

5 % calcium chloride injection in cardiac ganglionic Plexus during On pump Coronary artery bypass graft

DRUGSodium Chloride 0.9% Inj

0.9% sodium chloride injection during on pump during Coronary artery bypass graft


Locations(1)

Ain shams university

Cairo, Abassia Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06378021


Related Trials